α-synuclein, LRRK2 and their interplay in Parkinson's disease | Future Neurology
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro
Structural features of the alpha-synuclein monomer. A structure of the... | Download Scientific Diagram
3D structures of tau and alpha-synuclein proteins vary by brain disease, several studies show | National Institute on Aging
Alpha-Synuclein aggregation HTRF kit | Cisbio
IJMS | Free Full-Text | The Role of α-Synuclein Oligomers in Parkinson's Disease
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect
Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad | Molecular Neurodegeneration | Full Text
RCSB PDB - 1XQ8: Human micelle-bound alpha-synuclein
A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease
Zeroing in on neurodegenerative α-synuclein | Nature Reviews Drug Discovery
Alpha Synuclein in Parkinson's Disease Diagnostics | StressMarq
IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease
IJMS | Free Full-Text | Alpha Synuclein: Neurodegeneration and Inflammation
Role of Alpha-Synuclein Proteins in Disease
The Cellular Environment Affects Monomeric α-Synuclein Structure: Trends in Biochemical Sciences
Frontiers | Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson's Disease
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies | Nature Medicine
Active alpha-synuclein proteins | Abcam
Alpha Synuclein – The Science of Parkinson's
Targeting alpha-synuclein in the gut may slow | EurekAlert!
3D Structure of Alpha-Synuclein Challenges Previous Parkinson's Theory
Modulating membrane binding of α-synuclein as a therapeutic strategy | PNAS
